Drug Trial Radar · NCT06244082
Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping
Last checked: Nov 19, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
39
Actual
Start
Jan 22, 2024
Primary completion
Apr 30, 2027
Study completion Apr 30, 2027
Sponsor
- Lead sponsor
- Avidity Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 7 years, up to 27 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
AOC 1044-CS2 (EXPLORE44-OLE) is an Open-label Study to Evaluate the Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants with Mutations Amenable to Exon 44 Skipping.
Conditions
- DMD
- Duchenne Muscular Dystrophy
- Duchenne
- Exon 44
Interventions
AOC 1044Drug
AOC 1044 will be administered via intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment Emergent Adverse Events (TEAEs)Time frame: Through study completion (approximately 2 years)
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas
University of California, San Diego, Rady's Children's Hospital
La Jolla, California
UC Davis Medical Center
Sacramento, California
Lucille Packard Children's Hospital at Stanford
San Carlos, California
Rare Disease Research - Atlanta
Atlanta, Georgia
University of Massachusetts Medical School
Worcester, Massachusetts
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Rare Disease Research
Hillsborough, North Carolina
Abigail Wexner Research Institute at Nationwide Children's Hospital
Columbus, Ohio
Neurology Rare Disease Center
Denton, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.